Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Am J Hum Genet. 2010 Jun 11;86(6):892-903. doi: 10.1016/j.ajhg.2010.05.001. Epub 2010 May 20.
Genomic rearrangements involving the peripheral myelin protein gene (PMP22) in human chromosome 17p12 are associated with neuropathy: duplications cause Charcot-Marie-Tooth disease type 1A (CMT1A), whereas deletions lead to hereditary neuropathy with liability to pressure palsies (HNPP). Our previous studies showed that >99% of these rearrangements are recurrent and mediated by nonallelic homologous recombination (NAHR). Rare copy number variations (CNVs) generated by nonrecurrent rearrangements also exist in 17p12, but their underlying mechanisms are not well understood. We investigated 21 subjects with rare CNVs associated with CMT1A or HNPP by oligonucleotide-based comparative genomic hybridization microarrays and breakpoint sequence analyses, and we identified 17 unique CNVs, including two genomic deletions, ten genomic duplications, two complex rearrangements, and three small exonic deletions. Each of these CNVs includes either the entire PMP22 gene, or exon(s) only, or ultraconserved potential regulatory sequences upstream of PMP22, further supporting the contention that PMP22 is the critical gene mediating the neuropathy phenotypes associated with 17p12 rearrangements. Breakpoint sequence analysis reveals that, different from the predominant NAHR mechanism in recurrent rearrangement, various molecular mechanisms, including nonhomologous end joining, Alu-Alu-mediated recombination, and replication-based mechanisms (e.g., FoSTeS and/or MMBIR), can generate nonrecurrent 17p12 rearrangements associated with neuropathy. We document a multitude of ways in which gene function can be altered by CNVs. Given the characteristics, including small size, structural complexity, and location outside of coding regions, of selected rare CNVs, their identification remains a challenge for genome analysis. Rare CNVs may potentially represent an important portion of "missing heritability" for human diseases.
涉及人染色体 17p12 上外周髓鞘蛋白基因 (PMP22) 的基因组重排与神经病有关:重复导致 1A 型腓骨肌萎缩症 (CMT1A),而缺失导致遗传性神经病伴易压力性麻痹 (HNPP)。我们之前的研究表明,这些重排中的 >99%是反复发生的,由非等位基因同源重组 (NAHR) 介导。17p12 中也存在由非重复重排产生的罕见拷贝数变异 (CNV),但其潜在机制尚不清楚。我们通过寡核苷酸比较基因组杂交微阵列和断点序列分析研究了与 CMT1A 或 HNPP 相关的 21 个罕见 CNV 患者,鉴定出 17 个独特的 CNV,包括两个基因组缺失、十个基因组重复、两个复杂重排和三个小外显子缺失。这些 CNV 中的每一个都包含整个 PMP22 基因,或仅包含外显子,或包含 PMP22 上游的超保守潜在调节序列,进一步支持了 PMP22 是介导与 17p12 重排相关神经病表型的关键基因的论点。断点序列分析表明,与反复重排中的主要 NAHR 机制不同,各种分子机制,包括非同源末端连接、Alu-Alu 介导的重组和基于复制的机制 (例如 FoSTeS 和/或 MMBIR),可以产生与神经病相关的非重复 17p12 重排。我们记录了基因功能可以通过 CNV 改变的多种方式。鉴于选定的罕见 CNV 的特征,包括小尺寸、结构复杂性和位于编码区域之外,其鉴定仍然是基因组分析的一个挑战。罕见的 CNV 可能代表人类疾病“缺失遗传力”的重要部分。